ASAHI Road to 1000: Achieving Revenue of ¥80 Billion and an Operating Profit Margin of 25% for the Fiscal Year Ended June 2023
First written in FY2018. 16 of 25 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- FY2025AchievedAnnual report
「Under its medium-term management plan, ASAHI Going Beyond 1000, covering the five years from July 2021, the group set quantitative targets of consolidated net sales of ¥110 billion and an operating margin of 23–25% for the fiscal year ending June 2026, and established the following 4 basic policies. As a result of advancing its business under these policies, the group achieved the medium-term management plan's net sales and operating margin targets in the fiscal year ending June 2025, one year ahead of the original plan.」
The company achieved the ASAHI Going Beyond 1000 targets of net sales of ¥110 billion and an operating margin of 23–25% for the fiscal year ending June 2026 one year ahead of schedule, in the fiscal year ending June 2025. - FY2025-H1RestatedAnnual report
「The group has established the following 4 basic policies under its current medium-term management plan, ASAHI Going Beyond 1000, and aims to further enhance corporate value by steadily advancing these growth strategies.」
The company continues to pursue the growth strategy based on ASAHI Going Beyond 1000 and its 4 basic policies. This interim report presents no new changes to the plan's targets or deadlines. - FY2024RaisedAnnual report
「As a result, for the fiscal year ending June 2025, the company aims to achieve one year ahead of schedule the consolidated net sales target of ¥110 billion set for the final year of the medium-term management plan, the fiscal year ending June 2026.」
After achieving the ¥100 billion consolidated net sales milestone, the company set the final target of the medium-term management plan at ¥110 billion and indicated that it aims to achieve it one year ahead of schedule, in the fiscal year ending June 2025. - FY2024-Q3RestatedAnnual report
「Under its current medium-term management plan, ASAHI Going Beyond 1000, the Group is developing a business portfolio to grow beyond ¥100 billion in consolidated net sales and has established the following 4 basic policies: ① Strategic development of global markets and expansion of affected areas and treatment fields ② Creation of new businesses in global niche markets ③ Development of an R&D and production structure optimized for global expansion ④ Establishment of a management foundation for sustainable growth By steadily advancing these growth strategies, the Group aims to further enhance corporate value and plans to achieve the major milestone of ¥100 billion in consolidated net sales in the current fiscal year.」
Under ASAHI Going Beyond 1000, the company continues to pursue the plan to achieve consolidated net sales of ¥100 billion in the current fiscal year and the 4 basic policies. - FY2024-Q2RestatedAnnual report
「Under its current medium-term management plan, ASAHI Going Beyond 1000, the Group is developing a business portfolio to grow beyond ¥100 billion in consolidated net sales and has established the following 4 basic policies: ① Strategic development of global markets and expansion of affected areas and treatment fields ② Creation of new businesses in global niche markets ③ Development of an R&D and production structure optimized for global expansion ④ Establishment of a management foundation for sustainable growth By steadily advancing these growth strategies, the Group aims to further enhance corporate value and plans to achieve the major milestone of ¥100 billion in consolidated net sales in the current fiscal year.」
The company continues to pursue the 4 basic policies of ASAHI Going Beyond 1000 and the milestone of achieving consolidated net sales of ¥100 billion in the current fiscal year. - FY2024-Q1The company explicitly stated that it plans to achieve consolidated net sales of ¥100 billion in the current fiscal year.Annual report
「Under its current medium-term management plan, ASAHI Going Beyond 1000, the Group is developing a business portfolio to grow beyond ¥100 billion in consolidated net sales and has established the following 4 basic policies: ① Strategic development of global markets and expansion of affected areas and treatment fields ② Creation of new businesses in global niche markets ③ Development of an R&D and production structure optimized for global expansion ④ Establishment of a management foundation for sustainable growth By steadily advancing these growth strategies, the Group aims to further enhance corporate value and plans to achieve the major milestone of ¥100 billion in consolidated net sales in the current fiscal year.」
The company continued its 4 basic policies under ASAHI Going Beyond 1000 and explicitly stated that it plans to achieve consolidated net sales of ¥100 billion in the current fiscal year. - FY2023AdvancedAnnual report
「For the fiscal year ending June 2024, the company intends to maintain and expand its high growth by steadily implementing the growth strategy under the medium-term management plan. As a result, its earnings forecast for the fiscal year ending June 2024 is expected to exceed the milestone of consolidated net sales of ¥100 billion.」
The company is advancing the ASAHI Going Beyond 1000 growth strategy and indicated that consolidated net sales are expected to exceed ¥100 billion in the fiscal year ending June 2024. Forecast net sales are ¥100.353 billion. - FY2023-Q3RestatedAnnual report
「By pursuing minimally invasive treatment to the fullest, the Company aims to improve the QOL of physicians and patients. It is advancing the development of a business portfolio under the new medium-term management plan “ASAHI Going Beyond 1000,” with a target of exceeding ¥100 billion in consolidated net sales in the fiscal year ending June 2026 and achieving further long-term growth over the next 10 years. The plan sets out the following 4 basic policies.」
Under ASAHI Going Beyond 1000, the company continues to pursue the target of consolidated net sales exceeding ¥100 billion for the fiscal year ending June 2026 and build its business portfolio based on 4 basic policies. - FY2023-Q2AdvancedAnnual report
「As initiatives toward achieving this, during the first six months of the fiscal year, the company entered into (1) a basic agreement toward exclusive distribution in Japan of Penumbra Inc.'s thrombectomy devices for peripheral vessels, (2) an exclusive distribution agreement in China for DK MEDTECH (Suzhou) Co., Ltd.'s DK Score coronary scoring balloon catheter, (3) publication of the group's first Integrated Report 2022, and (4) a transfer agreement relating to the acquisition of shares in Lake R&D Co., Ltd., making it a non-consolidated subsidiary.」
Based on the ASAHI Going Beyond 1000 growth strategy, the company entered into the Lake R&D share acquisition agreement, in addition to sales partnerships and publication of the integrated report. - FY2023-Q1RestatedAnnual report
「By pursuing minimally invasive treatment to the fullest, the Company aims to improve the QOL of physicians and patients. It is advancing the development of a business portfolio under the new medium-term management plan “ASAHI Going Beyond 1000,” with a target of exceeding ¥100 billion in consolidated net sales in the fiscal year ending June 2026 and achieving further long-term growth over the next 10 years. The plan sets out the following 4 basic policies.」
Under ASAHI Going Beyond 1000, refreshed from ASAHI Road to 1000, the company continues to pursue the target of consolidated net sales exceeding ¥100 billion for the fiscal year ending June 2026 and a framework for long-term growth. - FY2022RestatedAnnual report
「Based on the five-year medium-term management plan ASAHI Going Beyond 1000 through the fiscal year ending June 2026, the group has pursued its growth strategy by developing a business portfolio to achieve further growth beyond consolidated net sales of ¥100 billion. It has sought to complete its existing basic strategy by strategically developing global markets and expanding its affected areas and treatment fields, strengthen the earnings base of existing businesses, continue investing in future growth, and create new businesses in global niche markets. It also aims to strengthen its presence in global niche markets and further enhance corporate value. To support this growth strategy, the group has worked to establish research and development and production systems optimised for global operations and to build a management foundation for sustainable growth.」
The company continues to build its business portfolio based on ASAHI Going Beyond 1000 through the fiscal year ending June 2026 and its 4 basic policies. - FY2022-Q1ReframedAnnual report
「By pursuing minimally invasive treatment to the fullest, the Company aims to improve the QOL of physicians and patients. It is advancing the development of a business portfolio under the new medium-term management plan “ASAHI Going Beyond 1000,” with a target of exceeding ¥100 billion in consolidated net sales in the fiscal year ending June 2026 and achieving further long-term growth over the next 10 years. The plan sets out the following 4 basic policies.」
The planning framework has shifted from ASAHI Road to 1000 to ASAHI Going Beyond 1000, setting out a new time horizon with a target of consolidated net sales exceeding ¥100 billion for the fiscal year ending June 2026. - FY2021ReframedAnnual report
「Against this backdrop, although the group is still within the period covered by its current medium-term management plan, it has newly formulated and refreshed a new medium-term management plan, ASAHI Going Beyond 1000, covering the five years beginning July 2021, with a view to the next 10 years. The strategy itself continues to follow the core strategy of the current medium-term management plan, with no major changes.」
The medium-term plan was refreshed from ASAHI Road to 1000 to ASAHI Going Beyond 1000, covering the five years beginning July 2021. The core strategy continues, reorganised within a framework focused on longer-term growth. - FY2021-Q3RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2021-Q2RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2021-Q1RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continued to maintain the interim targets under ASAHI Road to 1000 of ¥80 billion in consolidated sales and a 25% operating margin for the fiscal year ending June 2023. - FY2020RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2020-Q3RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2020-Q2RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2020-Q1RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2019RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continues to set the interim targets under ASAHI Road to 1000 of consolidated net sales of ¥80 billion and an operating margin of 25% for the fiscal year ending June 2023. - FY2019-Q3RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continued to maintain the interim targets under ASAHI Road to 1000 of ¥80 billion in consolidated sales and a 25% operating margin for the fiscal year ending June 2023. - FY2019-Q2RestatedAnnual report
「Under this plan, the company set a target of ¥80 billion in consolidated sales for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company continued to maintain the interim targets under ASAHI Road to 1000 of ¥80 billion in consolidated sales and a 25% operating margin for the fiscal year ending June 2023. - FY2019-Q1AdvancedAnnual report
「In August 2018, the group announced the medium-term management plan “ASAHI Road to 1000 — Aiming to become a strong global niche No. 1 through Only One technology,” which began with the consolidated first-quarter period under review.」
The company stated that ASAHI Road to 1000 was announced in August 2018 and began with the first quarter under review. The interim targets of ¥80 billion in consolidated sales and a 25% operating margin for the fiscal year ending June 2023 remained unchanged. - FY2018First statedAnnual report
「The company formulated a new medium-term management plan, “ASAHI Road to 1000 — Aiming to become a strong global niche No. 1 through Only One technology,” setting a target of consolidated sales of ¥80 billion for the fiscal year ending June 2023 as a milestone toward consolidated sales of ¥100 billion, with an operating margin target of 25% at that time.」
The company disclosed for the first time the new medium-term management plan following Global Expansion 2018, setting interim targets of ¥80 billion in sales and a 25% operating margin for the fiscal year ending June 2023 toward the long-term ¥100 billion sales target.